No Data
No Data
AIM ImmunoTech | 10-Q: Quarterly report
Express News | Todd Deutsch: Ted Kellner Intends to Submit Notice to AIM ImmunoTech Well in Advance of Deadline of Sept 13, 2024
Express News | Todd Deutsch: Ted Kellner Plans to Submit to AIM ImmunoTech Notice of Intent to Nominate Himself, Todd Deutsch,Chioini for Election to Co’s Board
AIM ImmunoTech to Discuss Second Quarter 2024 Financial Results on August 16, 2024, and Host Conference Call and Webcast
Express News | AIM ImmunoTech Announces New Pre-Clinical Data Showing Ampligen As Part Of Combination Therapy Slows Melanoma Tumor Growth And Improves Survival In Mouse Model
Express News | Aim Announces New Positive Data on Ampligen’s Anti-Tumor Potential When Used as Part of a Combination Therapy
No Data
HotShot369 OP : Ignore the aztr. sold some for profit and dilute cost went down
HotShot369 OP : Some of these plan to hold for a few days to 2 weeks
HotShot369 OP : now just realized I got posted everywhere I bought. WHAT THE FLIP
HotShot369 OP : I'm also watching rnaz
HotShot369 OP : mbio too
View more comments...